Clinical studies recruiting near Rome

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Same-Day Awake Mastectomy With Immediate Breast Reconstruction for Patients With Breast Cancer
NA · PTV Policlinico Tor Vergata University Hospital · University of Rome Tor Vergata · NCT07510698 A Study of Nipocalimab in Reducing the Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)
Phase 3 · Fondazione Policlinico Universitario A Gemelli IRCCS · Janssen Research & Development, LLC · NCT06449651 Observational Study Protocol: LIVER-R
Phase N/A · Research Site · AstraZeneca · NCT06252753 A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Phase 3 · Istituto Nazionale Tumori Regina Elena · Eli Lilly and Company · NCT07218380 Study on the Effects of Drugs That Modulate the Endocannabinoid System on Spontaneous and Induced Contractility of the H
Phase N/A · Fondazione Policlinico Universitario Agostino Gemelli IRCCS, · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT07545694 A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis
Phase 2 · Investigational Site Number : 3800011 · Sanofi · NCT06867094 This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · Istituto Nazionale Tumori Regina Elena · Pfizer · NCT07028853 GLS in Difficult CPB Weaning
Phase N/A · University of Rome Tor Vergata · Kartal Kosuyolu Yuksek Ihtisas Education and Research Hospit · NCT07390903 A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Phase 3 · Azienda Ospedaliera Universitaria Policlinico Tor Vergata · Takeda · NCT06747351 Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease
Phase 2/Phase 3 · Istituto Nazionale Tumori Regina Elena · Bristol-Myers Squibb · NCT07106762 Metabolomic Evaluation of Psycho-surgical Synergy on Body Image Restoration After Breast Cancer
NA · Sant'Andrea Hospital, Faculty of Medicine and Psychology "La · University of Roma La Sapienza · NCT05616988 Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase 3 · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Merck Sharp & Dohme LLC · NCT06393374 This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in
Phase 3 · Istituto Nazionale Tumori Regina Elena · Pfizer · NCT06758401 A Study to Evaluate How Pozelimab + Cemdisiran Combination Therapy Works in Adult Patients With Paroxysmal Nocturnal Hem
Phase 3 · Universita Cattolica del Sacro Cuore - Policlinico Universit · Regeneron Pharmaceuticals · NCT07154745 A Study Evaluating the Effects of Filgotinib in Children and Teenagers With Ulcerative Colitis
Phase 3 · Azienda Ospedaliero-Universitaria Policlinico Umberto I · Alfasigma S.p.A. · NCT06865417 A Study of Eptinezumab in Pediatric Participants With Episodic Migraine
Phase 3 · Ospedale Pediatrico Bambino Gesù IRCCS · H. Lundbeck A/S · NCT05897320 Association Between Sarcopenia And Diabetic Neuropathy In Adults With Type 1 Diabetes, A Pilot Study
NA · Fondazione Policlinico Universitario A. Gemelli IRCCS; UOC D · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT06902597 Predictive Factors for Massive Transfusion During Liver Transplantation
Phase N/A · Fondazione Policlinico Universitario A. Gemelli IRCCS · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT05763446 A Study of Zasocitinib in Adults With Nonsegmental Vitiligo
Phase 2 · Istituto Dermopatico Immacolata IDI, IRCCS · Takeda · NCT07108283 Immune Metabolism Dysregulation and Efficacy to Anti-PD-1 PD-L1 Agents in Non Small Cell Lung Cancer Patients
Phase N/A · IRCCS National Cancer institute · Regina Elena Cancer Institute · NCT07637474 A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carbop
Phase 3 · Azienda Ospedaliera San Camillo Forlanini · Hoffmann-La Roche · NCT06793215 Neoadjuvant Chemo-immunotherapy for Stage III PD-L1 Positive Non-Small Cell Lung Cancer (NSCLC)
Phase 2 · Istituti Fisioterapici Ospitalieri · Fondazione Ricerca Traslazionale · NCT07264647 Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
Phase 3 · PedAL BCU, LLC · NCT05183035 Randomization of Single vs Multiple Arterial Grafts
NA · European Hospital · Weill Medical College of Cornell University · NCT03217006 PK/PD Analysis of Ceftazidime/Avibactam or Cefiderocol With or Without Fosfomycin for the Treatment of Difficult To-trea
Phase N/A · Policlinico Umberto I · University of Bologna · NCT06651047 Observational Study on Skeletal Ewing's Sarcoma
Phase N/A · Istituto Regina Elena - IFO · Italian Sarcoma Group · NCT04845893 Preoperative vs Postoperative Hypofractionated Radiosurgery for Patients With Large Brain Metastases
NA · Policlinico Umberto I · Istituto Clinico Humanitas · NCT05545007 LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Phase 2 · Fondazione Policlinico Tor Vergata · Eli Lilly and Company · NCT07415044 A Study to Assess the Dose, Adverse Events, and Change in Disease Activity of Livmoniplimab as an Intravenous (IV) Solut
Phase 2/Phase 3 · Fondazione Policlinico Universitario Agostino Gemelli IRCCS- · AbbVie · NCT06109272 A Study to Learn About the Safety of Vedolizumab and How Well it Works in Children and Teenagers With Active Chronic Pou
Phase 3 · Azienda Ospedaliero-Universitaria Policlinico Umberto I · Takeda · NCT06443502

Look up another city

Look up another condition